Bu içeriği görüntülemek için JoVE aboneliği gereklidir. Oturum açın veya ücretsiz deneme sürümünü başlatın.
Method Article
This protocol describes a procedure for serial sampling of femoral bone marrow (BM) without requiring the sacrifice of mice. This procedure facilitates longitudinal studies of the BM composition of mice over time and provides serial access to cells within the BM for ex vivo and transplantation studies.
Serial sampling of the cellular composition of bone marrow (BM) is a routine procedure critical to clinical hematology. This protocol describes a detailed step-by-step technical procedure for an analogous procedure in live mice which allows for serial characterization of cells present in the BM. This procedure facilitates studies aimed to detect the presence of exogenously administered cells within the BM of mice as would be done in xenograft studies for instance. Moreover, this procedure allows for the retrieval and characterization of cells enriched in the BM such as hematopoietic stem and progenitor cells (HSPCs) without sacrifice of mice. Given that the cellular composition of peripheral blood is not necessarily reflective of proportions and types of stem and progenitor cells present in the marrow, procedures which provide access to this compartment without requiring termination of the mice are very helpful. The use of femoral bone marrow aspiration is illustrated here for cytological analysis of marrow cells, flow cytometric characterization of the hematopoietic stem/progenitor compartment, and culture of sorted HSPCs obtained by femoral BM aspiration compared with conventional marrow harvest.
All blood cells are derived from hematopoietic stem cells (HSCs). Procedures which allow access to the bone marrow (BM), the site of the vast majority of HSC’s in mice and men, without requiring sacrifice of animals, provide a resource to monitor the source of hematopoiesis serially. The overall goal of the procedure described here is to provide a detailed protocol for the sampling of BM cells from the femur of live mice which provides material representative of the cells which would be retrieved by conventional harvest of BM cells through sacrifice of the mice. The advantage of this procedure over conventional harvest of BM cells is that this procedure does not require the sacrifice of mice and therefore allows for longitudinal study of the bone marrow compartment of mice over time.
Although this murine bone marrow aspiration procedure has been used in a number of studies and described previously (see Sundberg et al. for a historical review1), formal step-by-step procedures illustrating this technique have not been previously published. This protocol enables routine serial sampling of the BM for purposes such as assessing engraftment in the BM of cells exogenously introduced into the mouse (as would be done in xenograft studies for instance2,3), analysis of chimerism in the BM for comparison with that of the peripheral blood (where results are not necessarily congruent), monitoring the abundance of specific cell types normally enriched in the marrow such as hematopoietic stem and progenitor cells, and retrieval of BM cells for ex vivo culture and/or transplantation. In addition, evaluation of marrow contents may be very useful in murine models of hematological disease as aspiration is helpful in assessing hematological disease burden at time points when disease may not be evident in the peripheral blood3-5. Moreover, this technique may be used to evaluate response of hematologic disease in the marrow to drugs administered in therapeutic studies. Thus, the procedure described here is ideal for investigators wishing to obtain access to bone marrow hematopoietic cells from mice for cytological analysis, flow cytometric analysis, in vitro culturing, and/or in vivo transplantation studies without requiring sacrifice or harm to the mice.
The protocol for sampling of BM described here is quite similar to the technique used for intra-femoral injection of material directly into the marrow cavity3,6. The key difference being that this protocol details the procedure for removal of cells from the marrow as opposed to instilling material directly into the marrow cavity space as is done with intrafemoral injection.
Bu protokolü açıklanan tüm hayvan prosedürleri Laboratuar Hayvanlarının Bakımı ve Kullanımı için Rehber uyarınca yapılmıştır ve Memorial Sloan-Kettering Kanser Merkezi'nde Kurumsal Hayvan Bakımı ve Kullanımı Komitesi (IACUCs) tarafından onaylanmıştır.
Femur Kemik İliği 1. Aspirasyon (BM) Hücreler
Emişli BM hücrelerinde hücresel İçerik 2. Değerlendirilmesi
Canlı bir C57/B6 fare femur BM aspirasyon kurban etme işleminden sonra, aynı fare BM geleneksel hasat ardından BM mononükleer hücreleri elde etmek için kullanılmıştır. Her iki yöntem ile elde edilen BM mononükleer hücreleri daha sonra, BM hücrelerinin (1), sitolojik analizi ile analiz (2) hematopoietik kök / progenitör hücrelerin nispi frekansı (HSPCs) belirlenmesi ve sıralanmış HSPCs (3) ex vivo kültür edilmiştir. Ikinci deney, soy-negatif SCA1 + c-KIT In + (LSK'ya) hücreleri BM a...
Seri BM aspirasyon insanlarda hematolojik hastalıkların klinik araştırma için kritik bir rutin bir işlemdir. Uzun deneyler boyunca hücresel bileşiminde ve BM bileşenlerinin karakterizasyonu için farelerde DM'nin benzer bir seri örnekleme gerçekleştirme yeteneği aynı şekilde çok değerlidir. Bu prosedür, fare ödün vermeden, aynı zamanda periferik kan içeriği BM yaşayan hücrelerin yansıtıcı olmayabilir durumda BM ek hücre tiplerinin varlığını tespit etmek için HSPC en karakterizasyonu...
Yazarlar ifşa hiçbir şey yok.
O.A.-W. is supported by an NIH K08 Clinical Investigator Award (1K08CA160647-01), a U.S. Department of Defense Postdoctoral Fellow Award in Bone Marrow Failure Research (W81XWH-12-1-0041), the Josie Roberston Investigator Program, and a Damon Runyon Clinical Investigator Award with Support from the Evan’s Foundation.
Name | Company | Catalog Number | Comments |
PBS | PAA | H15-002 | |
Bovine serum albumin | PAA | K41-001 | |
ACK lysis buffer | Homemade | in 1 L. Adjust pH 7.2 ~ 7.4 and filter sterile with 0.22 μm vacuum filter. | |
8.3 g Ammonium chloride | Fisher Scientific | A661-500 | |
1 g Potassium bicarbonate | Fisher Scientific | P184-500 | |
200 μl 0.5 M EDTA pH 8 | Gibco | 15575-038 | |
RPMI 1640 | PAA | E15-842 | |
0.5 ml Tuberculin syringe 27.5 G | Becton Dickinson | 305620 | |
Sterile cell strainer 70 μm | Fisher Scientific | 22363548 | |
Isoflurane, USP | Attane | NDC:66794-014-25 | |
Blunt-end needle | Stemcell Technologies | 28110 | |
PrecisionGlide needle 23 G | Becton Dickinson | 305193 | |
3 ml Syringe Luer-Lok tip | Becton Dickinson | 309657 | |
Non-tissue culture treated plate, 6 Well | Becton Dickinson | 351146 | |
12 x 75 mm 5 ml tubes | Becton Dickinson | 352054 | FACS staining |
12 x 75 mm 5 ml tubes with cell-strainer cap | Becton Dickinson | 352235 | FACS staining |
NK1.1 APC-Cy7 | Biolegend | 108723 | |
CD11b APC-Cy7 | Biolegend | 101225 | |
CD45R (B220) APC-Cy7 | Biolegend | 103223 | |
CD3 APC-Cy7 | Biolegend | 100222 | |
Ly-6G and Ly-6C (Gr-1) APC-Cy7 | Biolegend | 108423 | |
Ter119 APC-Cy7 | Biolegend | 116223 | |
CD19 APC-Cy7 | Biolegend | 302217 | |
CD4 APC-Cy7 | BioLegend | 317417 | |
CD117 (c-KIT) PE | BioLegend | 105808 | |
Ly-6A/E (Sca-1) PE-Cy7 | Biolegend | 122513 | |
CD34 APC | Biolegend | 128612 | |
CD16/32 e450 | eBioscience | 48-0161-82 | |
DAPI (4′,6-Diamidino-2-phenylindole dihydrochloride) | Sigma-Aldrich | 32670 | |
MethoCult GF M3434 | STEMCELLTECHNOLOGIES | 3434 | For methocellulose culture |
Carprofen | Crescent Chemical Company | C11045850 | 1 dose (5mg/kg) |
Flow cytometer, LSRFortessa | Becton Dickinson | ||
Puralube vet ointment (sterile petrolatum ophthalmic ointment) | Dechra-US | 17033-211-38 |
Bu JoVE makalesinin metnini veya resimlerini yeniden kullanma izni talebi
Izin talebiThis article has been published
Video Coming Soon
JoVE Hakkında
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır